250 related articles for article (PubMed ID: 15212822)
1. Cholesterol in neurologic disorders of the elderly: stroke and Alzheimer's disease.
Reiss AB; Siller KA; Rahman MM; Chan ES; Ghiso J; de Leon MJ
Neurobiol Aging; 2004 Sep; 25(8):977-89. PubMed ID: 15212822
[TBL] [Abstract][Full Text] [Related]
2. 24S-hydroxycholesterol: a marker of brain cholesterol metabolism.
Lütjohann D; von Bergmann K
Pharmacopsychiatry; 2003 Sep; 36 Suppl 2():S102-6. PubMed ID: 14574622
[TBL] [Abstract][Full Text] [Related]
3. Cholesterol homeostasis and the pathophysiology of Alzheimer's disease.
Blain JF; Poirier J
Expert Rev Neurother; 2004 Sep; 4(5):823-9. PubMed ID: 15853509
[TBL] [Abstract][Full Text] [Related]
4. The role of 24S-hydroxycholesterol in Alzheimer's disease.
Kölsch H; Lütjohann D; von Bergmann K; Heun R
J Nutr Health Aging; 2003; 7(1):37-41. PubMed ID: 12679839
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic potential of statins in Alzheimer's disease.
Kandiah N; Feldman HH
J Neurol Sci; 2009 Aug; 283(1-2):230-4. PubMed ID: 19321181
[TBL] [Abstract][Full Text] [Related]
6. Cholesterol and statins in Alzheimer's disease: current controversies.
Fonseca AC; Resende R; Oliveira CR; Pereira CM
Exp Neurol; 2010 Jun; 223(2):282-93. PubMed ID: 19782682
[TBL] [Abstract][Full Text] [Related]
7. Alzheimer's disease therapeutics: new approaches to an ageing problem.
Small DH; Losic D; Martin LL; Turner BJ; Friedhuber A; Aguilar MI
IUBMB Life; 2004 Apr; 56(4):203-8. PubMed ID: 15230347
[TBL] [Abstract][Full Text] [Related]
8. Cholesterol and Alzheimer's disease--is there a relation?
Sjögren M; Mielke M; Gustafson D; Zandi P; Skoog I
Mech Ageing Dev; 2006 Feb; 127(2):138-47. PubMed ID: 16332384
[TBL] [Abstract][Full Text] [Related]
9. Involvement of cholesterol in the pathogenesis of Alzheimer's disease: role of statins.
Pregelj P
Psychiatr Danub; 2008 Jun; 20(2):162-7. PubMed ID: 18587285
[TBL] [Abstract][Full Text] [Related]
10. Cholesterol and 24S-hydroxycholesterol trafficking in Alzheimer's disease.
Lukiw WJ
Expert Rev Neurother; 2006 May; 6(5):683-93. PubMed ID: 16734516
[TBL] [Abstract][Full Text] [Related]
11. Isoprenoids and Alzheimer's disease: a complex relationship.
Cole SL; Vassar R
Neurobiol Dis; 2006 May; 22(2):209-22. PubMed ID: 16406223
[TBL] [Abstract][Full Text] [Related]
12. Impact of HMG-CoA reductase inhibition on brain pathology.
Zipp F; Waiczies S; Aktas O; Neuhaus O; Hemmer B; Schraven B; Nitsch R; Hartung HP
Trends Pharmacol Sci; 2007 Jul; 28(7):342-9. PubMed ID: 17573124
[TBL] [Abstract][Full Text] [Related]
13. [Therapy of Alzheimer disease].
Kovács T
Neuropsychopharmacol Hung; 2009 Mar; 11(1):27-33. PubMed ID: 19731816
[TBL] [Abstract][Full Text] [Related]
14. Reduction in levels of 24S-hydroxycholesterol by statin treatment in patients with Alzheimer disease.
Vega GL; Weiner MF; Lipton AM; Von Bergmann K; Lutjohann D; Moore C; Svetlik D
Arch Neurol; 2003 Apr; 60(4):510-5. PubMed ID: 12707064
[TBL] [Abstract][Full Text] [Related]
15. Cholesterol-modifying strategies for Alzheimer's disease.
Solomon A; Kivipelto M
Expert Rev Neurother; 2009 May; 9(5):695-709. PubMed ID: 19402779
[TBL] [Abstract][Full Text] [Related]
16. Alterations in cholesterol metabolism as a risk factor for developing Alzheimer's disease: Potential novel targets for treatment.
Loera-Valencia R; Goikolea J; Parrado-Fernandez C; Merino-Serrais P; Maioli S
J Steroid Biochem Mol Biol; 2019 Jun; 190():104-114. PubMed ID: 30878503
[TBL] [Abstract][Full Text] [Related]
17. Relation between cholesterol levels, statins and Alzheimer's disease in the human population.
Austen B; Christodoulou G; Terry JE
J Nutr Health Aging; 2002; 6(6):377-82. PubMed ID: 12459888
[TBL] [Abstract][Full Text] [Related]
18. Prevention of stroke and dementia by statin therapy: experimental and clinical evidence of their pleiotropic effects.
Miida T; Takahashi A; Ikeuchi T
Pharmacol Ther; 2007 Feb; 113(2):378-93. PubMed ID: 17113151
[TBL] [Abstract][Full Text] [Related]
19. Statins: the role in the treatment and prevention of Alzheimer's neurodegeneration.
Pac-Soo C; Lloyd DG; Vizcaychipi MP; Ma D
J Alzheimers Dis; 2011; 27(1):1-10. PubMed ID: 21734347
[TBL] [Abstract][Full Text] [Related]
20. HMG-CoA reductase inhibitor simvastatin inhibits cell cycle progression at the G1/S checkpoint in immortalized lymphocytes from Alzheimer's disease patients independently of cholesterol-lowering effects.
Sala SG; Muñoz U; Bartolomé F; Bermejo F; Martín-Requero A
J Pharmacol Exp Ther; 2008 Jan; 324(1):352-9. PubMed ID: 17928568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
